Lee Borthwick

Lee Borthwick is Chief Executive Officer and Co-Founder of FibroFind, providing the leadership that connects FibroFind’s scientific capability directly to the needs of its biopharma clients.

Lee has been central to the development of FibroFind’s precision-cut tissue platform, working closely with academic partners and industry collaborators to establish its application in drug discovery and preclinical research. His background in translational research — leading multidisciplinary teams, developing laboratory capabilities and delivering client programs — means he understands what biopharma clients need from a scientific partner and how to ensure the business consistently delivers it.

As CEO, Lee is responsible for ensuring that FibroFind’s scientific ambition translates into reliable, high-quality programs that clients can depend on to support their most important development decisions.